Inflammation

BOSTON — Treatment with TERN-501, a selective thyroid hormone receptor beta agonist, reduced liver fat content and fibro-inflammation among patients with presumed metabolic dysfunction-associated steatohepatitis, late-breaking data showed.

A multidisciplinary approach is key to treating patients with corneal nerve dysfunction and neuropathic ocular pain, according to a speaker at Twin Cities Ocular Surface Disease Symposium.

PHILADELPHIA — Compared with controls, patients with chronic kidney disease showed greater accumulation of intermuscular adipose tissue that has a strong association with insulin resistance, according to data presented at ASN Kidney Week.

PHILADELPHIA — In this Healio exclusive, Deepak L. Bhatt, MD, MPH, provides his perspective on research presented at the American Heart Association Scientific Sessions.

A Canadian neuroimaging company has received an investment from the Alzheimer’s Drug Discovery Foundation to accelerate development of novel biomarkers for Alzheimer’s disease and related dementias.

Consumption of red meat was linked to an increased risk for type 2 diabetes, whereas replacing red meat with dairy, nuts and legumes reduced that risk, according to a recent study.

Elevating nicotinamide adenine dinucleotide with nicotinamide riboside supplementation reduced inflammation in both healthy controls and patients with psoriasis, according to findings from a clinical study.

BOSTON — In this Healio video exclusive, Paul M. Ridker, MD, MPH, discusses the use of low-dose colchicine to target inflammation in patients who remain at high CVD risk despite controlled LDL.

NEW YORK — In this Healio Video Perspective from OSN New York, John A. Hovanesian, MD, FACS, explains why he uses Dextenza to treat inflammation in most of his cataract surgery patients.

NEW YORK — In this Healio Video Perspective from OSN New York, Mitchell A. Jackson, MD, discusses the benefits of using Dextenza as a postoperative treatment for patients after cataract surgery.